Chalmers, James D.

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Abani, O., Abbas, A., Abbas, F., Abbas, M., Abbasi, S., Abbass, H., Abbott, A., Abdallah, N., Abdelaziz, A., Abdelfattah, M., et al. (2021) · The Lancet

COVID-19 Clinical Research StudiesRespiratory Support and Mechanisms

Cited by 1,983

The bronchiectasis severity index. An international derivation and validation study

Chalmers, J. D., Goeminne, P., Aliberti, S., McDonnell, M. J., Lonni, S., Davidson, J., Poppelwell, L., Salih, W., Pesci, A., Dupont, L. J., et al. (2014) · American Journal of Respiratory and Critical Care Medicine

Cystic Fibrosis Research AdvancesChronic Obstructive Pulmonary Disease (COPD) Research

Cited by 1,093

Control of confounding and reporting of results in causal inference studies. Guidance for authors from editors of respiratory, sleep, and critical care journals

Lederer, D. J., Bell, S. C., Branson, R. D., Chalmers, J. D., Marshall, R., Maslove, D. M., Ost, D. E., Punjabi, N. M., Schatz, M., Smyth, A. R., et al. (2019) · Annals of the American Thoracic Society

Advanced Causal Inference TechniquesStatistical Methods in Epidemiology

Cited by 715

Development and Reporting of Prediction Models: Guidance for Authors From Editors of Respiratory, Sleep, and Critical Care Journals

Leisman, D. E., Harhay, M. O., Lederer, D. J., Abramson, M., Adjei, A. A., Bakker, J., Ballas, Z. K., Barreiro, E., Bell, S. C., Bellomo, R., et al. (2020) · Critical Care Medicine

Statistical Methods in EpidemiologyMeta-analysis and systematic reviews

Cited by 271

The microbiome in respiratory medicine: current challenges and future perspectives

Faner, R., Sibila, O., Agustí, A., Bernasconi, E., Chalmers, J. D., Huffnagle, G. B., Manichanh, C., Molyneaux, P. L., Paredes, R., Pérez Brocal, V., et al. (2017) · European Respiratory Journal

Gut microbiota and healthChronic Obstructive Pulmonary Disease (COPD) Research

Cited by 247

Seven-day antibiotic courses have similar efficacy to prolonged courses in severe community-acquired pneumonia–a propensity-adjusted analysis.

Choudhury, G., Mandal, P., Singanayagam, A., Akram, A. R., Chalmers, J. D., & Hill, A. T. (2011) · Clinical Microbiology and Infection

Pneumonia and Respiratory InfectionsAntibiotic Use and Resistance

Cited by 59